Glycine is one of the most underrated compounds in the sleep science literature. It is not marketed as a sleep supplement — you won't find it prominently displayed in the sleep aisle alongside melatonin and valerian. It doesn't have the cultural cachet of ashwagandha or the brand recognition of magnesium. What it has is a specific, well-documented mechanism for improving sleep quality that most people in the sleep supplement space have never heard of.
Whether that qualifies it as a sleep supplement depends on how you define the category. What the research makes clear is that it does something real, through a mechanism that is distinct from anything else in the space, and that the clinical evidence behind it is more solid than most of what sits on the sleep supplement shelf.
What Glycine Is
Glycine is the simplest amino acid — a single carbon separating an amino group from a carboxylic acid group, with two hydrogen atoms attached. It is non-essential, meaning the body can synthesise it, but the rate of synthesis does not always meet physiological demand, particularly under conditions of high collagen turnover, physical stress, or metabolic load.
Dietary sources of glycine are concentrated in collagen-rich foods: bone broth, skin-on poultry, connective tissue, and gelatin. These are foods that have become less prevalent in modern diets as processing has moved away from whole-animal eating patterns. The functional consequence is that many adults are producing and consuming less glycine than their physiology optimally uses.
At supplemental doses — typically 3 grams taken before sleep — glycine produces effects that dietary sources alone rarely deliver consistently.
The Core Mechanism: Core Body Temperature
The sleep mechanism that makes glycine genuinely interesting is not the one most people would guess. It is not primarily sedation, GABA activation, or melatonin synthesis. It is thermoregulation.
Sleep onset requires a drop in core body temperature. This is not incidental to sleep — it is a physiological prerequisite. The hypothalamus initiates sleep partly by detecting the temperature decline, and the transition into deep slow-wave sleep is associated with the body reaching its thermal nadir for the night. Anything that accelerates or deepens that temperature drop facilitates both sleep onset and sleep depth.
Glycine accelerates the core body temperature drop through peripheral vasodilation — the widening of blood vessels in the skin and extremities that dissipates heat from the body's core to the surface. Research from Osaka City University's Department of Integrative Physiology, which has produced the most rigorous glycine sleep research to date, found that glycine supplementation before sleep significantly reduced core body temperature compared to placebo, with corresponding improvements in sleep quality measures.
The temperature effect is measurable and occurs within the first hour of ingestion. This is faster than the GABA pathway effects of magnesium, the cortisol modulation of ashwagandha, or any gut-sleep mechanism. It is an acute mechanism, not a deficiency correction — which means it works on the first night, not after weeks of consistent use.
What the Osaka City University Research Found
The Osaka City University research group has published multiple papers examining glycine's effects on sleep in human subjects, making it one of the better-characterised single-compound sleep interventions in the peer-reviewed literature.
In a double-blind, placebo-controlled trial, participants with self-reported sleep complaints took 3 grams of glycine before bed and completed both subjective and objective sleep assessments. The glycine group showed:
Significant reductions in time to sleep onset — falling asleep faster than placebo. Significant improvements in sleep quality scores — feeling more rested on waking. Significant improvements in daytime sleepiness and cognitive performance the following morning — specifically on tasks requiring sustained attention and working memory.
Critically, the objective assessment using polysomnography found that glycine reduced time spent in light sleep (N1) without reducing total sleep time — meaning more of the available sleep time was spent in deeper, more restorative stages. This is an architectural improvement, not just a subjective one.
A subsequent study examined the mechanism directly, measuring peripheral skin temperature — the signal of vasodilation — alongside core body temperature. Glycine supplementation produced measurable increases in peripheral temperature and decreases in core temperature, confirming the thermoregulatory mechanism rather than leaving it as a hypothesis.
The daytime performance findings are particularly relevant for the Optimiser and Professional ICP. The research found that glycine's sleep quality improvements translated into measurable next-day cognitive benefits — reduced fatigue, better sustained attention — which is the outcome that matters for high-performing individuals. Sleep quality is a means to an end. The end is daytime function.
Glycine as an Inhibitory Neurotransmitter
The thermoregulation mechanism is the primary pathway for sleep onset effects, but glycine has a second, distinct mechanism relevant to sleep: it functions as an inhibitory neurotransmitter in the brainstem and spinal cord.
GABA is the primary inhibitory neurotransmitter in the brain. Glycine performs a similar inhibitory function specifically in the brainstem — reducing neuronal excitability in regions that govern arousal, muscle tone, and the transition between sleep stages. This glycinergic inhibition is particularly active during REM sleep, where it contributes to the muscle atonia characteristic of that stage.
Supplemental glycine crosses the blood-brain barrier efficiently and increases glycinergic signalling in these regions. This is hypothesised to contribute to the deeper, more consolidated sleep observed in the research — not through sedation, but through increased inhibitory tone in the circuits that regulate sleep architecture.
The dual mechanism — peripheral thermoregulation and central inhibitory signalling — makes glycine unusual in the sleep supplement space. Most compounds operate through a single pathway. Glycine's effects on both body temperature and brainstem inhibitory tone may explain why the research findings are more consistent than many single-mechanism compounds.
How Glycine Relates to Magnesium Bisglycinate
This is the connection most people haven't made, and it's the reason glycine has particular relevance to anyone taking magnesium bisglycinate for sleep.
Magnesium bisglycinate is magnesium chelated with two glycine molecules. The chelation is what gives the compound its superior absorption profile compared to oxide or carbonate forms — the glycine stabilises the magnesium through digestive transit and facilitates transport across the intestinal wall. But the glycine in the compound is not simply a carrier. It is a pharmacologically active molecule that is released once absorbed.
A well-formulated magnesium bisglycinate supplement delivers both magnesium — for GABA receptor support, deep sleep facilitation, and cortisol modulation — and glycine — for the thermoregulatory and brainstem inhibitory mechanisms described above. The two compounds have complementary mechanisms that address sleep onset and sleep depth through different and non-overlapping pathways.
This is why the choice of magnesium form is more consequential than it appears on the surface. Magnesium oxide delivers magnesium at 4% absorption and no glycine. Magnesium bisglycinate delivers magnesium at high absorption rates and the full glycine dose in addition. The difference is not marginal — it is the difference between one active mechanism and two.
Moongreens uses Albion® magnesium bisglycinate — a pharmaceutical-grade chelated form that delivers both the magnesium and the glycine in every serving. The thermoregulatory and inhibitory effects of glycine are built into the formula through the chelation choice, not as a separate addition. For anyone evaluating why the form of magnesium matters, this is part of the answer that rarely gets explained.
What Glycine Doesn't Do
Honest characterisation requires noting the limitations alongside the evidence.
Glycine does not address cortisol dysregulation. It does not directly support GABA receptor function in the same way magnesium does — its inhibitory effects are in different neural regions, through different receptors (glycine receptors rather than GABA-A receptors). It does not improve microbiome health or gut-sleep axis function. And its effects, while acute, are primarily on sleep onset and early sleep architecture rather than on the full-night cortisol management that determines early morning waking.
For someone whose primary sleep problem is cortisol-driven early waking, glycine alone is a partial intervention. For someone whose primary problem is lying awake at bedtime with a body that won't cool down efficiently, it is more directly targeted.
Most people with sleep quality issues have multiple contributing mechanisms. The most effective interventions address several simultaneously — which is why a formula combining magnesium bisglycinate (delivering both magnesium and glycine), ashwagandha (for cortisol), and gut-sleep axis support (for serotonin and SCFA production) covers more of the problem than any single compound taken in isolation.
The Practical Takeaway
Glycine is a legitimate sleep compound with a specific, well-documented mechanism and a solid clinical evidence base — most of it from Osaka City University's research group. Its primary action is thermoregulatory: it accelerates core body temperature reduction through peripheral vasodilation, facilitating faster sleep onset and deeper early sleep stages. Its secondary action is inhibitory neurotransmission in the brainstem, contributing to more consolidated sleep architecture.
It is not a sedative. It does not produce drowsiness. It acts acutely — within the first night of use — rather than requiring weeks of deficiency correction. And it is almost entirely absent from mainstream sleep supplement marketing, which means it represents one of the more underutilised evidence-based options available.
The most practical route to consistent glycine delivery for sleep is magnesium bisglycinate — which delivers both compounds simultaneously, in a single chelated form, with each reinforcing the mechanisms the other doesn't address.
Glycine doesn't tell your brain to sleep — it tells your body to cool down, and your brain follows.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.